Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti- ganglioside G(D2) immunocytochemistry

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2024-2030

  Lode, H N ^a   Handgretinger, R ^a   Schuermann, U ^a   Seitz, G ^a   Klingebiel, T ^a   Niethammer, D ^a   Beck, J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Anti G(D2) immunocytochemistry; Autologous transplantation; CD34+ selection; Minimal residual disease; Nested PCR; Neuroblastoma; Peripheral blood stem cells; Purging; Tyrosine hydroxylase

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTIGENS, CD34; ANTIGENS, NEOPLASM; BONE MARROW PURGING; CELL SEPARATION; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, AUTOLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 0031431540     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00243-8     Document Type: Conference Paper

References (32)

1. Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11, 1466-1477.
2. Philip T, Bernard JL, Zucker JM, et al. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol 1987, 5, 266-271.
3. Seeger R. C., Reynolds C. P. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am. 38:1991;393-424.
4. Klingebiel T, Handgretinger R, Herter M, et al. Peripheral stem cell transplants in neuroblastoma stage 4 with the use of [131I-m]IBG. Prog Clin Biol Res 1994, 385, 309-317.
5. Evans AE, August CS, Kamani N, et al. Bone marrow transplantation for high risk neuroblastoma at the children's hospital of Philadelphia: an update. Med Pediatr Oncol 1994, 23, 323-327.
6. Combaret V, Favot MC, Kremens B, et al. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer 1989, 59, 844-847.
7. Dominici C, Deb G, Angioni A, et al. Peripheral blood stem cells in children with solid tumors. Part II. Immunocytologic detection of tumor cells in bone marrow and peripheral blood stem cell harvests. Anticancer Res 1993, 13, 2573-2575.
8. Moss T. J., Sanders D. G., Lasky L. C., Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood. 76:1990;1879-1883.
9. Moss TJ, Cairo M, Santana VM, et al. Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 1994, 83, 3085-3089.
10. Lebkowski JS, Schain LR, Okrongly D, et al. Rapid isolation of human CD34 hematopoietic stem cells-purging of human tumor cells. Transplant 1992, 53, 1011-1019.
11. Nagai J, Kigasawa H, Tomioka K, et al. Immunocytochemical detection of bone marrow-invasive neuroblastoma cells. Eur J Haematol 1994, 53, 74-77.
12. Berthold F., Schneider A., Schumacher R., Bosslet K. Detection of minimal disease in bone marrow of neuroblastoma patients by immunofluorescence. Pediatr Hematol Oncol. 6:1989;73-83.
13. Moss T. J., Sanders D. G. Detection of neuroblastoma cells in blood. J Clin Oncol. 8:1990;736-740.
14. Moss TJ, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991, 324, 219-226.
15. Mattano L. A., Moss T. J., Emerson S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 52:1992;4701-4705.
16. Naito H, Kuzumaki N, Uchino J, et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 1991, 27, 762-765.
17. Burchill S. A., Bradbury F. M., Smith B., Lewis I. J., Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer. 57:1994;671-675.
18. Miyajima Y., Kato K., Numata S., Kudo K., Horibe K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer. 75:1995;2757-2761.
19. Tuchman M., Ramnaraine M. L., Woods W. G., Krivit W. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics. 79:1987;203-205.
20. Lode HN, Bruchelt G, Seitz G, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta- iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer 1995, 31A, 586-590.
21. Handgretinger R, Klingebiel T, Dopfer R, et al. Peripheral stem cell collection and transplantation in pediatric patients. Prog Clin Biol Res 1992, 377, 615-620.
22. Chirgwin J. M., Przbyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
23. Beck J, Handgretinger R, Dopfer R, et al. Expression of mdr1, mrp, topoisomerase IIalpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol 1995, 89, 356-363.
24. Grima B, Lamouroux A, Boni C, et al. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 1987, 326, 707-711.
25. Kobayashi K, Kaneda N, Ichinose H, et al. Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem Tokyo 1988, 103, 907-1012.
26. Nishi M, Miyake H, Takeda T, et al. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma. Eur J Pediatr 1990, 149, 859-861.
27. Sasaki H, Momoi T, Yamanaka C, et al. Changes in the ganglioside composition of human neuroblastoma cells under different growth conditions. Int J Cancer 1991, 47, 742-745.
28. Schengrund C. L., Shochat S. J. Gangliosides in neuroblastomas. Neurochem Pathol. 8:1988;189-202.
29. Brenner MK, Rill DR, Holladay MS, et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993, 342, 1134-1137.
30. Rill DR, Santana VM, Roberts WM, et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994, 84, 380-383.
31. Bensinger WI, Berenson RJ, Andrews RG, et al. Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation. J Clin Apheresis 1990, 5, 74-76.
32. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991, 77, 1717-1722.